The possibilities that Artificial Intelligence could bring to the workplace and educational institutions is both amazing and ...

A Carnegie Mellon sports betting class focuses on the difficulty of winning, while Harvard hosts speakers who tout the ...

Alto Neuroscience, Inc. ( (ANRO)) has shared an announcement. On April 1, 2026, Alto Neuroscience reported topline Phase 2 proof-of-concept data for ALTO-101 in cognitive impairment associated with ...

As of Monday, April 13, Alto Neuroscience, Inc.’s ANRO share price has surged by 6.32%, which has investors questioning if ...

Detailed price information for Alto Neuroscience Inc (ANRO-N) from The Globe and Mail including charting and trades.

— In the proof-of-concept study, ALTO-101 did not achieve statistical significance on primary endpoint; signals observed across EEG measures including near-significant improvement in theta-ITC ...

Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced topline data from its Phase 2 ...

HE PERFORMED AT SUMMERFEST IN JULY. >> COCKROACHES. COLLEGE STUDENTS IN NEUROSCIENCE. A NEW EXPERIMENT AT MARQUETTE UNIVERSITY IS COMBINING THOSE THREE THINGS TO EDUCATE THE NEXT GENERATION OF HEALTH ...

David Sussillo did not have an auspicious beginning in life. He grew up in Albuquerque’s International District when it was commonly called the War Zone with parents who struggled with addiction, and ...

Have you ever felt calmer almost as soon as you step into the woods? Or maybe noticed your busy mind soften as you look out at the sea? We have known for some time, and many of us sense it intuitively ...